Naoto Hirano (N Hirano)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 14

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Nature biotechnology

Nature medicine

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Giselle M Boukhaled, Ramy Gadalla, Heidi J Elsaesser, Diala Abd-Rabbo, Rene Quevedo, S Y Cindy Yang, Mengdi Guo, Ben X Wang, Babak Noamani, Diana Gray, Sally C M Lau, Kirsty Taylor, Kyaw Aung, Anna Spreafico, Aaron R Hansen, Samuel D Saibil, Naoto Hirano, Cynthia J Guidos, Trevor J Pugh, Tracy L McGaha, Pamela S Ohashi, Adrian G Sacher, Marcus O Butler, David G Brooks
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy. Nature immunology 23 (8) (2022)
Kenji Murata, Dalam Ly, Hiroshi Saijo, Yukiko Matsunaga, Kenji Sugata, Fumie Ihara, Daisuke Oryoji, Yota Ohashi, Kayoko Saso, Chung-Hsi Wang, Evey Y F Zheng, Brian D Burt, Marcus O Butler, Naoto Hirano
Modification of the HLA-A*24:02 Peptide Binding Pocket Enhances Cognate Peptide-Binding Capacity and Antigen-Specific T Cell Activation. Journal of immunology (Baltimore, Md. : 1950) 209 (8) (2022)
Koji Kato, Munehide Nakatsugawa, Serina Tokita, Yoshihiko Hirohashi, Terufumi Kubo, Tomohide Tsukahara, Kenji Murata, Hirofumi Chiba, Hiroki Takahashi, Naoto Hirano, Takayuki Kanaseki, Toshihiko Torigoe
Characterization of Proteasome-Generated Spliced Peptides Detected by Mass Spectrometry. Journal of immunology (Baltimore, Md. : 1950) 208 (12) (2022)
Susan J Done, Nisha Kanwar, Zaldy Balde, Ranju Nair, Melanie Dawe, Shiyi Chen, Manjula Maganti, Atenafu G Eshetu, Sabrina Manolescu, Carrie X Wei, Amanda Mao, Fred Fu, Dan Wang, Alison Cheung, Yulia Yerofeyeva, Rachel Peters, Kela Liu, Christine Desmedt, Christos Sotiriou, Borbala Szekely, Janina Kulka, Trevor D McKee, Naoto Hirano, Timothy J Whelan, Martin Joel Yaffe, Philippe L Bedard, David McCready
Heterogeneity of circulating tumor cell-associated genomic gains in breast cancer and its association with the host immune response. Cancer research (2021)
Kenji Sugata, Yukiko Matsunaga, Yuki Yamashita, Munehide Nakatsugawa, Tingxi Guo, Levon Halabelian, Yota Ohashi, Kayoko Saso, Muhammed A Rahman, Mark Anczurowski, Chung-Hsi Wang, Kenji Murata, Hiroshi Saijo, Yuki Kagoya, Dalam Ly, Brian D Burt, Marcus O Butler, Tak W Mak, Naoto Hirano
Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells. Nature biotechnology 39 (8) (2021)
Kenji Murata, Munehide Nakatsugawa, Muhammed A Rahman, Linh T Nguyen, Douglas G Millar, David T Mulder, Kenji Sugata, Hiroshi Saijo, Yukiko Matsunaga, Yuki Kagoya, Tingxi Guo, Mark Anczurowski, Chung-Hsi Wang, Brian D Burt, Dalam Ly, Kayoko Saso, Alexandra Easson, David P Goldstein, Michael Reedijk, Danny Ghazarian, Trevor J Pugh, Marcus O Butler, Tak W Mak, Pamela S Ohashi, Naoto Hirano
Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma. eLife 9 (2020)
Patricia M Benveniste, Munehide Nakatsugawa, Linh Nguyen, Pamela S Ohashi, Naoto Hirano, Juan-Carlos Zúñiga-Pflücker
In vitro-generated MART-1-specific CD8 T cells display a broader T-cell receptor repertoire than ex vivo naïve and tumor-infiltrating lymphocytes. Immunology and cell biology 97 (4) (2019)
Patricia M Benveniste, Sobhan Roy, Munehide Nakatsugawa, Edward L Y Chen, Linh T Nguyen, Douglas G Millar, Pamela S Ohashi, Naoto Hirano, Erin J Adams, Juan-Carlos Zúñiga-Pflücker
Generation and molecular recognition of melanoma-associated antigen-specific human γδ T cells. Science immunology 3 (30) (2019)
Yuki Kagoya, Shinya Tanaka, Tingxi Guo, Mark Anczurowski, Chung-Hsi Wang, Kayoko Saso, Marcus O Butler, Mark D Minden, Naoto Hirano
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects. Nature medicine 24 (3) (2018)
Yuki Kagoya, Munehide Nakatsugawa, Kayoko Saso, Tingxi Guo, Mark Anczurowski, Chung-Hsi Wang, Marcus O Butler, Cheryl H Arrowsmith, Naoto Hirano
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models. Nature communications 9 (1) (2018)
P Achita, D Dervovic, D Ly, J B Lee, T Haug, B Joe, Naoto Hirano, L Zhang
Infusion of ex-vivo expanded human TCR-αβ+ double-negative regulatory T cells delays onset of xenogeneic graft-versus-host disease. Clinical and experimental immunology 193 (3) (2018)
Mark Anczurowski, Yuki Yamashita, Munehide Nakatsugawa, Toshiki Ochi, Yuki Kagoya, Tingxi Guo, Chung-Hsi Wang, Muhammed A Rahman, Kayoko Saso, Marcus O Butler, Naoto Hirano
Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84Gly. Scientific reports 8 (1) (2018)
Tingxi Guo, Ming Yin Koo, Yuki Kagoya, Mark Anczurowski, Chung-Hsi Wang, Kayoko Saso, Marcus O Butler, Naoto Hirano
A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1+ TCRs. Journal of immunology (Baltimore, Md. : 1950) 200 (2) (2017)
Kenji Chamoto, Tingxi Guo, Stephen W Scally, Yuki Kagoya, Mark Anczurowski, Chung-Hsi Wang, Muhammed A Rahman, Kayoko Saso, Marcus O Butler, Priscilla P L Chiu, Jean-Philippe Julien, Naoto Hirano
Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs. Journal of immunology (Baltimore, Md. : 1950) 198 (3) (2016)

Naoto Hirano.css-eqlu8i{font-size:small;padding-left:4px;} (N Hirano)

Publication Activity (10 Years)

Top Topics

Top Venues

Naoto Hirano (N Hirano)